ACT Receives Second 510(k) Clearance for Occlusion Perfusion Catheter

Advanced Catheter Therapies has received a second 510(k) clearance from the FDA for the company’s Occlusion Perfusion Catheter.

The multi-lumen balloon catheter provides targeted intravascular drug delivery. It temporarily occludes a specific region from blood flow to allow the local delivery of therapeutic agents to the peripheral, and eventually the coronary vasculature.

The company can now offer delivery options for vessels 3mm - 10mm in diameter and disease length up to 15cm in length.

Chattanooga, Tenn.-based ACT is a provider of catheter technologies targeting vascular diseases including thrombosis, inflammation, occlusions and restenosis. — Michael Cipriano